Higher levels of copeptin and S-100B on MRI were associated with increased stroke severity, as evidenced by higher National Institutes of Health Stroke Scale (NIHSS) scores, and were predictive of poorer clinical outcomes, including an increased risk of mortality and disability following a stroke. The gene discussed is AVP; the disease is stroke disorder.